Heritage Wealth Management (Arizona)’s Supernus Pharmaceuticals SUPN Stock Holding History

Heritage Wealth Management (Arizona)’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$442K	Buy	12,378 +6,964	+129%	+$242K	0.06%	230
2022 Q3	$183K	Buy	5,414 +224	+4%	+$7.29K	0.06%	244
2022 Q2	$150K	Buy	5,190 +671	+15%	+$19.2K	0.05%	287
2022 Q1	$146K	Buy	+4,519	New	+$139K	0.04%	322
2021 Q3	$61K	Buy	2,272 +616	+37%	+$16.5K	0.02%	423
2021 Q2	$51K	Buy	1,656 +655	+65%	+$20.1K	0.02%	449
2021 Q1	$26K	Buy	+1,001	New	+$28K	0.01%	457

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ACB

Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return

Heritage Wealth Management (Arizona)'s SUPN Position: Q4 2022 in Review

Heritage Wealth Management (Arizona) increased its Supernus Pharmaceuticals (SUPN) stake by 129% in Q4 2022, buying an estimated $242K and bringing the position to 12,378 shares worth $442K. The position accounts for 0.06% of the portfolio, ranked #230.

Heritage Wealth Management (Arizona) first reported a position in SUPN in Q1 2021 and has held it in 7 quarters since. 263 funds tracked by Wall St. Rank hold SUPN as of Q4 2022.

Heritage Wealth Management (Arizona) held 12,378 shares of Supernus Pharmaceuticals worth $442K as of Q4 2022.
Heritage Wealth Management (Arizona) bought 6,964 Supernus Pharmaceuticals shares in Q4 2022, an estimated $242K.
Supernus Pharmaceuticals made up 0.06% of Heritage Wealth Management (Arizona)'s portfolio in Q4 2022, its #230 holding.
Heritage Wealth Management (Arizona) first reported a position in Supernus Pharmaceuticals in Q1 2021 and has held it in 7 quarters since.
263 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q4 2022.

Based on Heritage Wealth Management (Arizona)'s 13F filing for Q4 2022, filed 13 Feb 2023.